)
Boston's sky-high investment volume snowballed in the summer, including a record-setting office deal and massive multifamily price tags.
)
City officials, life sciences tenants and their landlords are assessing the impact of sustainability measures on the industry and on redevelopment projects.
)
Biotech Monte Rosa Therapeutics has entered an agreement for 63K SF at BioMed Realty's office-to-lab project at 321 Harrison Ave. in Boston's South End.
)
Investors flocked to data centers during the pandemic, and new survey data and industry insiders suggest they are staying for the long haul.
)
Royal Group, an Abu Dhabi investment firm controlled by the emirate's ruling family, plans to invest in stocks and assets, including real estate.
)
The office REIT reported a net loss for Q3 as it took a $273M impairment charge due to falling office values.
)
The Supreme Court’s striking down of affirmative action will challenge CRE’s waning DEI commitment.
)
Don't count on foreign investment activity to spike anytime soon as investors remain cautious about the economy and property values.
)
A series of distressed situations have arisen in the weeks since Labor Day, a trend experts say is a precursor of more to come.
)
The voluntary surrender of office buildings made up a third of all foreclosures in the first half of this year, the highest proportion since at least 2019.
We're not asking for your money. This is not a step towards a paywall. Our news is free and we intend to keep it that way.